Marine-Derived Dual BTK-FGFR Inhibitors: Pioneering a New Era of Precision Oncology Therapeutics.
- DOI
- 10.2174/0118715206464059260420095736
- Published
- 2026 Jun 8
- Container
- Anti-cancer agents in medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/0118715206464059260420095736,
title = {Marine-Derived Dual BTK-FGFR Inhibitors: Pioneering a New Era of Precision Oncology Therapeutics.},
author = {Kundral S and Kumar A and Gupta P and Bodla R and Kumar D},
year = {2026},
journal = {Anti-cancer agents in medicinal chemistry},
doi = {10.2174/0118715206464059260420095736},
url = {https://doi.org/10.2174/0118715206464059260420095736}
}RIS
TY - JOUR TI - Marine-Derived Dual BTK-FGFR Inhibitors: Pioneering a New Era of Precision Oncology Therapeutics. AU - Kundral S AU - Kumar A AU - Gupta P AU - Bodla R AU - Kumar D PY - 2026 JO - Anti-cancer agents in medicinal chemistry DO - 10.2174/0118715206464059260420095736 UR - https://doi.org/10.2174/0118715206464059260420095736 ER -
APA
S, K., A, K., P, G., R, B., & D, K. (2026). Marine-Derived Dual BTK-FGFR Inhibitors: Pioneering a New Era of Precision Oncology Therapeutics.. Anti-cancer agents in medicinal chemistry. https://doi.org/10.2174/0118715206464059260420095736
Source records
- pubmed · retrieved 2026-09-27T10:03:48.185Z